The outlook of companies tied to Sildenafil's legacy presents a intricate investment scenario . While the initial surge generated substantial returns , generic competition have significantly eroded market https://fellowfavorite.com/story23011687/copyright-s-flagship-product-and-big-pharma-a-risky-investment